L. Ramanathan

发表

Expression, purification, stability optimization and characterization of human Aurora B kinase domain from E. coli.

A. Basso, Yan-Hui Liu, Rumin Zhang, 2010, Archives of biochemistry and biophysics.

Crystal structures of the pro-inflammatory cytokine interleukin-23 and its complex with a high-affinity neutralizing antibody.

P. Orth, V. Madison, B. Beyer, 2008, Journal of molecular biology.

Characterization of a major form of rat hepatic microsomal cytochrome P-450 induced by isoniazid.

P. Thomas, C. Lieber, J. Shively, 1985, The Journal of biological chemistry.

Binding affinities and geometries of various metal ligands in peptide deformylase inhibitors.

P. Weber, T. Fischmann, A. Cooper, 2002, Biophysical chemistry.

Purification and characterization of mouse beta-2 microglobulin: allelic variants from two different strains.

E. Appella, E. Robinson, G. Dubois, 1982, Molecular immunology.

Rat hepatic cytochrome P-450 isozyme specificity for the metabolism of the steroid sulfate, 5 alpha-androstane-3 alpha, 17 beta-diol-3,17-disulfate.

P. Thomas, W. Levin, R. Evans, 1984, Archives of biochemistry and biophysics.

Mouse beta 2-microglobulin cDNA clones: a screening procedure for cDNA clones corresponding to rare mRNAs.

J. Seidman, A. Felsenfeld, E. Appella, 1981, Proceedings of the National Academy of Sciences of the United States of America.

Lack of histocompatibility antigens on a murine ovarian teratocarcinoma.

R. Fisher, E. Appella, L. Ramanathan, 1981, Cancer research.

Structure and humanization of a rat monoclonal Fab to human interleukin-5.

W. Cook, S. Narula, N. Murgolo, 1996, Protein engineering.

Avian riboflavinuria—XI. Immunological quantitation of cross-reacting liver proteins from normal, heterozygous, and mutant hens

E. Buss, S. Listwak, R. Guyer, 1980, Biochemical Genetics.

Multiple forms of recombinant murine interleukin-4 expressed in COS-7 monkey kidney cells.

N. Arai, H. Le, T. L. Nagabhushan, 1989, Biochimica et biophysica acta.

Isolation and structure elucidation of two novel deformylase inhibitors produced by Streptomyces sp.

P. Shipkova, A. Hruza, J. Terracciano, 2001 .

Chemical modifications of riboflavin-binding protein: effects on function and antigenicity.

E. Buss, R. Guyer, L. Ramanathan, 1980, Molecular immunology.

Biochemical analysis of a 40,000 mol. wt mouse serum protein which binds beta 2-microglobulin and has serological cross-reactivity with H-2 antigens.

E. Appella, V. Hearing, E. Robinson, 1982, Molecular immunology.

Immunochemistry of the glycopeptide derived from avian riboflavin-binding protein.

E. Buss, R. Guyer, W. Karakawa, 1979, Molecular immunology.

Control of H-2 antigen and beta 2-microglobulin gene expression in mouse trophoblast cell clones.

J. Seidman, E. Appella, K. Tanaka, 1983, Proceedings of the National Academy of Sciences of the United States of America.

Discovery of the HCV NS3/4A protease inhibitor (1R,5S)-N-[3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3- [2(S)-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]- 6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2(S)-carboxamide (Sch 503034) II. Key steps in structure-based optimization.

Zhuyan Guo, Frank Bennett, Rong-Sheng Yang, 2007, Journal of medicinal chemistry.

Solution structure and dynamics of the single-chain hepatitis C virus NS3 protease NS4A cofactor complex.

J. Gesell, M. Senior, D. Wyss, 2001, Journal of molecular biology.

Immunochemical mapping of domains in human interleukin 4 recognized by neutralizing monoclonal antibodies.

L. Sullivan, R. Ingram, H. Le, 1993, Biochemistry.

Probing the substrate specificity of hepatitis C virus NS3 serine protease by using synthetic peptides

W. Windsor, Rumin Zhang, J. Durkin, 1997, Journal of virology.

Enhancement of hepatitis C virus NS3 proteinase activity by association with NS4A-specific synthetic peptides: identification of sequence and critical residues of NS4A for the cofactor activity.

P. Mui, R. Jubin, B. Dasmahapatra, 1996, Virology.

Hepatitis C NS3 protease: restoration of NS4A cofactor activity by N-biotinylation of mutated NS4A using synthetic peptides.

Z. Hong, B. Dasmahapatra, N. Yao, 2000, Biochemical and biophysical research communications.

Purification and characterization of truncated human AMPK alpha 2 beta 2 gamma 3 heterotrimer from baculovirus-infected insect cells.

P. Sheth, Li Xiao, H. Le, 2010, Protein expression and purification.

Selective proteolytic cleavage of recombinant human interleukin 4. Evidence for a critical role of the C-terminus.

W. Windsor, H. Le, P. Trotta, 1991, Biochemistry.

Isolation and characterization of multiple variants of recombinant human interleukin 4 expressed in mammalian cells.

Y. Takebe, N. Arai, H. Le, 1988, The Journal of biological chemistry.

Purification and characterization of mouse beta-2-microglobulin variants from two different strains. Abstr.

E. Appella, E. Robinson, G. Dubois, 1981 .

Structure-guided discovery of cyclin-dependent kinase inhibitors.

Emma Lees, David Parry, Kamil Paruch, 2008, Biopolymers.

Serine protease of hepatitis C virus expressed in insect cells as the NS3/4A complex.

A. Kwong, P. Weber, Z. Hong, 1998, Biochemistry.

Screening and rank ordering of reversible mechanism-based inhibitors of hepatitis C virus NS3 protease using electrospray ionization mass spectrometry.

B. Malcolm, Yan-Hui Liu, B. Pramanik, 2011, Journal of mass spectrometry : JMS.

Rat hepatic cytochrome P-450 isozyme specificity for the metabolism of the steroid sulfate, 5α-androstane-3α,17β-diol-3,17-disulfate

P. Thomas, W. Levin, R. Evans, 1984 .

Discovery of a Potent, Injectable Inhibitor of Aurora Kinases Based on the Imidazo-[1,2-a]-Pyrazine Core.

Patrick J. Curran, Ming Liu, R. Doll, 2010, ACS medicinal chemistry letters.

Crystal structures of the pro-inflammatory cytokine interleukin-23 and its complex with a high-affinity neutralizing antibody.

P. Orth, V. Madison, B. Beyer, 2008, Journal of Molecular Biology.

Discovery of the HCV NS3/4A Protease Inhibitor SCH503034. Key Steps in Structure-Based Optimization

P. Weber, M. Senior, Z. Hong, 2007 .